131 related articles for article (PubMed ID: 20709009)
1. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model.
Yamamoto S; Wada J; Katayama T; Jikimoto T; Nakamura M; Kinoshita S; Lee KM; Kawabata M; Shirakawa T
Vaccine; 2010 Sep; 28(41):6684-91. PubMed ID: 20709009
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered Bifidobacterium animalis expressing the Salmonella flagellin gene for the mucosal immunization in a mouse model.
Takata T; Shirakawa T; Kawasaki Y; Kinoshita S; Gotoh A; Kano Y; Kawabata M
J Gene Med; 2006 Nov; 8(11):1341-6. PubMed ID: 16958059
[TBL] [Abstract][Full Text] [Related]
3. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
Negi VD; Singhamahapatra S; Chakravortty D
Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of purified Vi polysaccharide typhoid vaccine.
Park JH; Hong JJ; Choi ES; Lee JW; Park JH
J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
Paliwal PK; Bansal A; Sagi SS; Sairam M
Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
[TBL] [Abstract][Full Text] [Related]
8. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
[TBL] [Abstract][Full Text] [Related]
9. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages.
Synnott A; Ohshima K; Nakai Y; Tanji Y
Biotechnol Prog; 2009; 25(2):552-8. PubMed ID: 19334277
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.
Long RT; Zeng WS; Chen LY; Guo J; Lin YZ; Huang QS; Luo SQ
Int J Obes (Lond); 2010 Apr; 34(4):712-9. PubMed ID: 20065960
[TBL] [Abstract][Full Text] [Related]
14. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
15. Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods.
Lundgren A; Kaim J; Jertborn M
Vaccine; 2009 Jul; 27(33):4529-36. PubMed ID: 19446596
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies against the lipopolysaccharide of Salmonella typhi 9,12,VI:d. Analysis of passive protection in a mouse model of typhoid fever].
Paniagua J; Isibasi A; Pelayo R; Ortiz V; Muy M; González C; García JA; Islas S
Arch Invest Med (Mex); 1989; 20(4):315-20. PubMed ID: 2488771
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
18. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
[TBL] [Abstract][Full Text] [Related]
19. The use of live attenuated Salmonella for oral vaccination.
Chatfield S; Roberts M; Li J; Starns A; Dougan G
Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
